gms | German Medical Science

German Congress of Orthopaedics and Traumatology (DKOU 2024)

22. - 25.10.2024, Berlin

Dislocation following two-stage revision total hip arthroplasty: A comprehensive risk factor analysis

Meeting Abstract

  • presenting/speaker Stavros Goumenos - Charité – Universitätsmedizin,CMSC, Berlin, Germany
  • Christian Hipfl - Charité – Universitätsmedizin,CCM, Berlin, Germany
  • Bernhard Michalski - Charité – Universitätsmedizin,CCM, Berlin, Germany
  • Olga Pidgaiska - Charité – Universitätsmedizin,CMSC, Berlin, Germany
  • Ulrich Stöckle - Charité – Universitätsmedizin,CMSC, Berlin, Germany
  • Carsten Perka - Charité – Universitätsmedizin,CCM, Berlin, Germany
  • Sebastian Meller - Charité – Universitätsmedizin,CMSC, Berlin, Germany

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2024). Berlin, 22.-25.10.2024. Düsseldorf: German Medical Science GMS Publishing House; 2024. DocAB49-3070

doi: 10.3205/24dkou225, urn:nbn:de:0183-24dkou2253

Published: October 21, 2024

© 2024 Goumenos et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Objective: Dislocation following revision total hip arthroplasty is a serious complication and the primary cause for revision surgery after two-stage exchange total hip arthroplasty (THA) due to periprosthetic joint infection (PJI).

The aims of our study were (1) to determine the incidence of dislocation after two-stage THA reimplantation without spacer placement, (2) to evaluate relevant risk factors for dislocation and (3) to assess the efficacy of dual-mobility constructs to mitigate instability.

Methods: We prospectively analyzed 187 patients who underwent a two-stage revision THA after being diagnosed with PJI from 2013 to 2019. 36 patients (19%) received a dual-mobility construct. The mean duration of follow-up was 54.2±24.9 months (>36 months). The incidence of postoperative dislocation and subsequent revision was estimated through Kaplan-Meier curves and potential risk factors were identified using Cox hazard regression. The functional outcome of the patients was assessed using the modified Harris Hip Score (mHHS).

Results: The estimated cumulative dislocation-free survival was 87.2% (95% CI: 81.2%–91.3%) with an estimated 10% and 12% risk for dislocation within the first 6 and 12 months, respectively. The use of a dual-mobility construct had no significant impact on the dislocation rate. Increasing body mass index (BMI) (HR=1.11, 95% CI: 1.02–1.19, p=0.011), abductor mechanism impairment (HR=2.85, 95% CI: 1.01–8.01, p=0.047), the extent of elongation of the affected extremity between stages (HR=1.04, 95% CI: 1.01–1.07, p=0.017), the final leg length discrepancy (HR=1.04, 95% CI: 1.01–1.08, p=0.018) and PJI recurrence (HR=2.76, 95% CI: 1.00–7.62, p=0.049) were found to be significant risk factors for dislocation. Overall revision rates were 17%. Unstable hips were 62% more likely to undergo re-revision surgery (p<0.001, Log-rank= 78.05). A significant average increase of 30 points in mHHS scores after second-stage reimplantation (p=0.001, Wilcoxon-rank) was recorded, but no difference in the final HHS measurements between stable and unstable hips.

Conclusion: Dislocation rates after two-stage THA reimplantation remain high independent of the use of dual-mobility constructs. Besides careful leg length restoration, an intact abductor mechanism appears to be critical to ensure stability in these complex patients.